Press Releases
Click links below to view press releases
Tactile Systems Technology Completes Accreditation with ACHC
Minneapolis — June 16, 2008 — Tactile Systems Technology (www.tactilesystems.com) has been awarded accreditation status by the Accreditation Commission for Health Care, Inc. (ACHC). Tactile Systems Technology provides a patented, innovative, at-home therapy through its Flexitouch® System to improve the health and quality of life for individuals with lymphedema. Lymphedema is a chronic, progressive medical condition affecting more than two million people in the United States. It is caused by a disruption to, or malformation of, the lymphatic system resulting in the accumulation of excessive amounts of fluid, most commonly in the arms, legs and torso. It is often an unintended consequence of cancer treatment.
Accreditation is a voluntary activity in which health care organizations submit to peer review of their internal policies, processes and patient care delivery against national standards. By attaining accreditation, Tactile Systems Technology has demonstrated its commitment to maintaining a higher level of competency and is striving for excellence in its products, services and customer satisfaction.
“This accreditation is a fitting acknowledgement of the life–changing therapy delivered by the Flexitouch system,” said Gerald R. Mattys, Chief Executive Officer, Tactile Systems Technology, “and it validates the hard work that has gone into the development of our products and services.”
ACHC, a private, not–for–profit corporation which is certified to ISO 9001:2000 standards, was developed by home care and community–based providers to help companies improve business operations and quality of patient care. Referring to the value of accreditation, ACHC President Tom Cesar said, “The survey process leads an organization to examine its policies and practices continually to clarify its strengths and improve its weaknesses.”
Tactile Systems Technology, Inc. was founded in 1995 to develop and market a medical device for the effective treatment of lymphedema and venous insufficiencies. It received U.S. Food and Drug Administration (FDA) marketing clearance for the device in 2002. The Flexitouch system has been proven effective in relieving the symptoms of lymphedema and has recently received marketing clearance from the FDA for the treatment of wounds.
In 2007, Tactile Systems Technology was named “Corporation of the Year” by the Lymphatic Research Foundation.